ANTISUPERBUGS: Open Market Consultation Questionnaire
INSTRUCTIONS

This questionnaire* is opened to all economic operators with the main goal to collect all relevant feedback on ANTISUPERBUGS (ASB) Pre-Commercial Procurement procedure and objectives.

Prior to the submission of the questionnaire, to all the respondents are advised:

- To meet with at least one of the consortium partners or have attended to one of the ASB Market Consultation Days or Industry Engagement Events such as the ones held on 15.12.2017 at AQuAS (Barcelona), on 18.01.2018 at Improving Infection Control within Healthcare conference, University of Salford,(Manchester), on 24.1.2018 at ZENIT Headquarters (Germany), or on 31.01.2018January 31st, 2018 at the Province of Trento (Italy);

- To carefully review the latest version of the definition of ASB procurement scope (here attached: Overview of ASB procurement scope and ASB use case Scenarios).

All details are available on the project website: http://antisuperbugs.eu/index.php/market-consultation-2/, where you will find the videos, and presentations that you must consult before answering the questionnaire.

All the respondents are invited to answer to all the questions. No field is mandatory and respondents can just answer to what they consider most appropriate.

The market consultation aims to:

— find out whether technologies are commercially available and acquire information about the advantages & disadvantages and the level of fulfilment of the desired functionalities;

— identify market risks that may endanger business goals and supplier performance;

— enable and increase the opportunities for industry to form fit-for-purpose consortia.

This questionnaire is a support tool for achieving the aims of the Market Consultations.

All the answers will be taken into account. However, no questionnaire will be considered if sent out anonymously.

Taking part to this survey is not a pre-requisite for the participation in the ASB Pre-commercial Procurement (PCP) procedure and does not give advantage to any supplier.


In case you are having issues to fill in the questionnaire, please contact is at : antisuperbugs.aquas@gencat.cat

* All information provided by You, by filling out the questionnaire, will be used (in a not binding way) exclusively for the purpose of the realization of this market consultation.
AQUAS, except as hereinafter provided about the processing of personal data, will undertake not to disclose to third parties the information collected with this document.
By sending the questionnaire, You will provide the consent to the processing of Your personal data provided.
Pursuant to Art. 5 of Spanish Law 15/1999. of 13 December, on the Protection of Personal data (“Law 15/1999”) and Royal Decree 1720/2007, of 21 December.

Email address *
Information on your organization
Please provide a brief description of the organization(s) submitting the questionnaire
Company / Organization 1 *
Your answer
Address (street, postcode, city, country) *
Your answer
Contact person *
Your answer
Title of contact person *
Your answer
Mobile number
Your answer
email *
Your answer
Kind of organisation: SME, large company, start-up, spin-off, etc *
Your answer
Year your organization was founded *
Your answer
Number of employees *
Your answer
Main focus of the company /organisation *
Your answer
In case of Consortium:
If a consortium is constituted, please describe associated organization(s)
Company / Organization 2
Your answer
Address (street, postcode, city, country)
Your answer
Contact person
Your answer
Title of contact person
Your answer
Year your organization was founded
Your answer
Mobile number
Your answer
email
Your answer
Kind of organisation: SME, large company, start-up, spin-off, etc
Your answer
Number of employees
Your answer
Main focus of the company /organisation
Your answer
Experience in developing technologies related with medical devices, microbial detection, Infection control , ICT etc
Your answer
State of the art and Organisation’s future development
Why the ANTI-SUPERBUGS PCP is an opportunity for the Industry:

- Challenge: Common Needs, functional requirements and Business Case : http://antisuperbugs.eu/wp-content/uploads/2018/01/ASB_NeedsFunctReqsBusinessCasev2.pdf

- Beyond State of the Art : http://antisuperbugs.eu/wp-content/uploads/2018/01/BeyondSoAv7.pdf

Challenge Brief: Common Needs, Functional Requirements and Business Case
Beyond State of the Art
Give a brief description of your company, specifying in particular the main market sectors in which it is specialized, and the main activities t in relation with ASB needs.
Your answer
In case your current activities are not related directly to ASB needs, please describe why you are considering participation?
Your answer
What market potential do you foresee for a commercial solution for the ASB challenge? and why ASB contracts could be strategic for your business?
Your answer
What technologies, services and /or commercial products do you supply that could address ASB needs?
Your answer
What is competitive advantage, compared with potential existing competitive technologies, products or services, would your solution provide to ASB needs?
Your answer
Pre-commercial procurement call
Why the ANTI-SUPERBUGS PCP is an opportunity for the Industry:

Description of ANTI-SUPERBUGS PCP procedures & legal framework: Hints and Tips.
- The description of the planned procurement procedure : http://antisuperbugs.eu/wp-content/uploads/2018/01/ASB_DescrProcurement_v2.pdf

PCP Legal Framework
Is the scope of the challenge clear? Please specify what is not clear and suggest how you could support ASB consortium to clarify further the needs
Your answer
Do you have any remark regarding the PCP phases?
Your answer
Regarding the use case scenario 1, do you think you could provide a near-to-market solution at the end of ASB PCP as defined?
Your answer
Use-case scenarios
A PCP for smart ICT solutions against Multi-resistant microorganisms
Regarding the use case scenario 1, do you think you could provide a near-to-market solution at the end of ASB PCP as defined?
Captionless Image
Your answer
Regarding the use case scenario 2, do you think you could provide a near-to-market solution at the end of ASB PCP as defined?
Captionless Image
Your answer
Regarding the use case scenario 3, do you think you could provide a near-to-market solution at the end of ASB PCP as defined?
Captionless Image
Your answer
Is your organisation able to produce prototypes to the required medical device regulations/standards?
Your answer
What criteria do you consider important to evaluate bidders’ proposals?
Your answer
Please provide a rough estimate of how much funding you would be likely to request for your R&D services at each Phase?
Your answer
Is your organization interested in bidding for this tender?If the answer is NO, can you explain why?
Your answer
If the answer is YES, are you planning to bid by your own or in consortium with other organizations? Please explain the added value of each of the partners of the consortium
Your answer
Submit
Never submit passwords through Google Forms.
reCAPTCHA
This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Additional Terms